Clinical Trial Update: ALVAC-HIV vCP1452 Alone and Combined With MN rgp120 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating ALVAC-HIV vCP1452 alone and with MN rgp120 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• ALVAC-HIV vCP1452
• MN rgp120 (rgp120)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, HIV Seronegativity | Phase 2 | Status: COMPLETED